Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma
author
statement of authorship
Simone Jueliger, John Lyons, Sara Cannito, Illar Pata, Pille Pata, Marianna Shkolnaya, Oriana Lo Re, Marion Peyrou, Francesc Villarroya, Valerio Pazienza, Francesca Rappa, Francesco Cappello, Mohammad Azab, Pietro Taverna, and Manlio Vinciguerra
source
Epigenetics
journal volume number month
vol. 11, 10
year of publication
pages
p. 709-720 : ill
subject term
keyword
decitabine
guadecitabine
hepatocellular carcinoma (HCC)
histone macroH2A1
steatohepatitis
ISSN
1559-2294
notes
Bibliogr.: 45 ref
TTÜ department
language
inglise
Jueliger, S., Lyons, J., Cannito, S., Pata, I., Pata, P., Školnaja, M. et al. Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma // Epigenetics (2016) vol. 11, 10, p. 709-720 : ill.